In summary, our results demonstrated that Znf179 can arrest GBM cells in the G0/G1 phase through p53-p21-p27 cell cycle signaling pathways and reprogram GBM cells into a more-differentiated phenotype. The gene discussed is RNF112; the disease is glioblastoma.